In Depth 7 Nov 2018 Biohacking: Democratization of Science or Just a Quirky Hobby? …protein DNA into Lactobacillus, and physicist Rob Carlson created an entire lab in his garage. This movement has frequently been compared to the computer revolution, in which the passion and… November 7, 2018 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 28 Jun 2018 The Race to Get CRISPR to the Clinic: Hope Versus Hype …for developing the technology — Jennifer Doudna, UC Berkeley and Feng Zhang at the Broad Institute — has been particularly notable. While there are now a number of companies in… June 28, 2018 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2017 One Mouse with All-Human Antibodies …DNA molecules. The appearance of transgenic mice The Trianni Mouse is the only transgenic antibody discovery platform that offers the entirety of the human antibody gene diversity in one single… November 29, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2025 Paper mills are a network: scientific fraud growing rapidly …these papers can be problematic,” said Byrne. Many of these papers contained blatant disinformation where reagents and polymerase chain reaction (PCR) primers – DNA sequences involved in the process of… September 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Dec 2020 A Year to Remember: The Biggest European Biotech News in 2020 …cancer drugs that prevent tumor cells from repairing their DNA, called DNA damage response inhibitors. In a strike for the antibody-drug conjugate field, Boehringer Ingelheim purchased the Swiss biotech NBE… December 28, 2020 - 12 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2016 German Record-deal Antiviral drug Succeeds in Phase III …now, the trial has met its primary endpoint: reducing the percentage of bone marrow transplant patients with significant CMV infections. Unlike CMV treatments in the market, which target DNA polymerase,… October 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 26 Oct 2022 Study shows ability to develop and apply targeted treatment in head and neck cancers …cellular characteristics of the tumors using DNA sequencing of 127 tissue samples from affected patients. They used artificial intelligence (AI) and positron emission tomography (PET) as an imaging method. The… October 26, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 9 Feb 2017 Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD …working relationship with a manufacturer, Delphi Genetics, to generate our DNA plasmid based product. Your technology aims to reinstate Immune Tolerance. Why did you choose IBD as an indication? IBD… February 9, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2017 Resilient Tumor Cells Drive Breast Cancer Relapse in Mice …turn that steer oxidative DNA damage, which they believe, to cause tumor recurrence. The results from mouse models were consistent with samples from patients. Using chemical inhibitors, the researchers then… May 25, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 22 Jul 2022 The coming of age story of RNAi technology …there were times when it seemed RNAi therapies might be consigned to the dustbin of ideas that failed. As every biology student learns early on, DNA makes RNA and RNA… July 22, 2022 - 7 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
News and Trends 15 Aug 2019 Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once …genome editing technique, CRISPR-Cas9, uses the DNA-cutting enzyme Cas9 and an RNA molecule that guides Cas9 where to cut on the genome. Instead of Cas9, this latest study published in… August 15, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2020 Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy …and hemophilia A. The company will also expand its gene therapy manufacturing capacity. The company’s technology consists of delivering therapeutic DNA into patients via a viral vector. The technology has… July 2, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email